Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

489.10 +3.21 (+0.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
59 60 Next >
CRISPR Therapeutics Just Slashed Its Staff by 10%. Should Shareholders Be Worried?
The timing of the cuts is setting off alarm bells, but the situation is under control. 
Via The Motley Fool
Healthcare Gems: 3 Essential Long-Term Stock Picks
Global healthcare spending reached a record $9 trillion in 2020. Catch the ongoing benefits with these three long-term healthcare stock picks. 
Via InvestorPlace
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics
Shareholders will do well to prepare themselves for how regulators might react. 
Via The Motley Fool
5 Unstoppable Trends to Invest $1,000 in for 2024
These next-big-thing trends represent some of the most exciting moneymaking opportunities for investors next year. 
Via The Motley Fool
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
These three gene therapy stocks should get huge boosts over the long term from the use of gene editing techniques to treat diseases. 
Via InvestorPlace
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
Vertex Appoints Nancy Thornberry to its Board of Directors
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today
Via Benzinga
Better Growth Stock: CRISPR Therapeutics vs. Invitae
One of these stocks may be riskier than the other... 
Via The Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach. 
Via The Motley Fool
A Bull Market Is Coming. Here Are 3 Stocks You'll Absolutely Want to Own.
These stocks are already big winners in 2023 and should keep their momentum going in a new bull market. 
Via The Motley Fool
Where Will Vertex Pharmaceuticals Be in 10 Years?
Vertex shares have soared 400% over the past decade. 
Via The Motley Fool
3 No-Brainer Growth Stocks to Buy in December
No analysis paralysis is required with these great stocks. 
Via The Motley Fool
Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now
The one thing these two stocks have in common is tremendous growth prospects. 
Via The Motley Fool
5 Top Stocks to Buy Before 2024
These stocks have room to run -- next year and over the long term. 
Via The Motley Fool
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
It's not as long a shot as some might think. 
Via The Motley Fool
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist
These stocks offer enormous long-term growth potential. 
Via The Motley Fool
3 Biotech Stocks That Could Be Multibaggers in the Making
Uncover investment opportunities with biotech stocks representing firms developing critical breakthroughs in treatments. 
Via InvestorPlace
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies. 
Via InvestorPlace
Biotech And Healthcare Portfolio Playbook For December 2023/24
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January. 
Via Talk Markets
5 Stocks You Can Confidently Invest $500 In Right Now
These companies could significantly grow your investment over the long haul. 
Via The Motley Fool
2 Healthcare Stocks That Could Help Set You Up for Life
Both companies are leaders in their fields. 
Via The Motley Fool
Investing in These 3 Stocks Now Could Make You a Millionaire Retiree
These innovators should have tremendous long-term growth prospects. 
Via The Motley Fool
4 First-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
The innovation-fueled Nasdaq Composite is still 11% below its all-time high, which means bargains abound for opportunistic investors. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
European Commission Approves KAFTRIO® in Combination With Ivacaftor for the Treatment of Children With Cystic Fibrosis Ages 2 Through 5
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Prediction: 3 Stocks That Could Trounce the Market
These stocks have what it takes to be huge winners over the next several years. 
Via The Motley Fool
3 Biotech Stocks That Could Be Millionaire Makers
Many biotech stocks offer exciting long-term growth prospects. 
Via The Motley Fool
Here's How Much $100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today
Via Benzinga
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street
Investment bank analysts are pounding the table on these stocks, but are they right for your portfolio? 
Via The Motley Fool
Could Investing $10,000 In CRISPR Therapeutics Stock Make You a Millionaire?
The stock is trading below its peak, reached a couple of years ago. 
Via The Motley Fool
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
59 60 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.